MedTrace Logo

Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients (ACNDM2)

NCT02931773 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-10-13

No results posted yet for this study

Summary

The investigators are studying the initial autonomic alterations in participants recently diagnosed with DM2 and in those patients classified as Pre-Diabetes, mainly focused on the baroreceptor sensitivity and on the peripheral sympathetic innervation.

Conditions

  • Dysautonomia

Interventions

DEVICE

Task Force® Monitor

A head up tilt test carried out with a Task Force monitoring system

Sponsors & Collaborators

  • Instituto Nacional de Cardiologia Ignacio Chavez

    lead OTHER

Principal Investigators

  • Manuel A Sierra-Beltrán, MD · Instituto Nacional De Cardiología "Ignacio Chávez"

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-07-31
Completion
2017-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02931773 on ClinicalTrials.gov